How ICER Misses What Matters

AfPA's Patient Access Podcast by Alliance for Patient Access

Feb 20, 20200:24:09Government & Organizations

Gunnar Esiason, a cystic fibrosis advocate, explains why the Institute for Clinical and Economic Review’s model for determining drugs' value doesn't sit well with patients.

Related Episodes

Continue listening to more episodes from AfPA's Patient Access Podcast.

Insurance Denials Leave Infants Unprotected

Jun 4, 2020 - 0:17:21

In this episode, Suzanne Staebler, DNP unpacks new data showing that vulnerable infants are denied access...

The Real Story on Gout

May 15, 2020 - 0:18:08

Renowned expert Larry Edwards, MD, explains why history has given gout a bad rap -- and why patients need...

Tardive Dyskinesia Patients’ New Resource

Apr 29, 2020 - 0:08:31

In this episode, Kathleen Shea explains how her experience with tardive dyskinesia motivated her to creat...

How Insurers Hold Headache Patients Back

Apr 17, 2020 - 0:09:43

Modern medicine has changed the way people living with headache and migraine disease can manage their con...

Moms, Don't Underestimate the Benefits of Seafood

Mar 26, 2020 - 0:16:08

Tom Brenna, PhD, has a recommendation for expectant and breastfeeding moms: Don't leave the benefits of s...

America's Heart Disease Crisis

Mar 12, 2020 - 0:11:28

In this episode, Dharmesh Patel, MD, explains how patient-centered care and prevention can help reverse t...

When Two is Better than One

Dec 20, 2019 - 0:10:47

Calli Cook, DNP, explains how combining preventive medications can vastly improve migraine patients' qual...

The Cancer Care Struggle

Nov 21, 2019 - 0:12:58

Jeffrey VanDeusen, MD, PhD, explains how certain policies make it difficult to deliver patient-centered c...